![Matinas BioPharma Holdings, Inc. logo](/logos/MTNB.webp)
Matinas BioPharma Holdings, Inc.
AMEX:MTNB
Overview | Financials
Company Name | Matinas BioPharma Holdings, Inc. |
Symbol | MTNB |
Currency | USD |
Price | 0.235 |
Market Cap | 50,970,367 |
Dividend Yield | 0% |
52-week-range | 0.11 - 0.89 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jerome D. Jabbour J.D. |
Website | https://www.matinasbiopharma.com |
An error occurred while fetching data.
About Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD